Premenstrual dysphoric disorder

Search with Google Search with Bing
Information
Disease name
Premenstrual dysphoric disorder
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05327075 Active, not recruiting Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian Females March 15, 2022 December 2022
NCT00518570 Completed N/A Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD) November 2003 October 2006
NCT00536198 Completed Phase 4 Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder November 6, 2007 February 2012
NCT00620581 Completed Phase 3 Luteal Phase Administration of Paroxetine for the Treatment of PMDD
NCT00678574 Completed Phase 4 The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder March 1998 December 2008
NCT00927095 Completed Phase 4 Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD) July 2008 July 2014
NCT01799733 Completed N/A Alternative Treatments for Premenstrual Dysphoric Disorder June 18, 2013 July 3, 2018
NCT03697265 Completed Phase 2 A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD) April 20, 2018 October 23, 2020
NCT03862469 Completed N/A Premenstrual Hormonal and Affective State Evaluation (PHASE) Project September 26, 2019 September 1, 2023
NCT06136104 Completed N/A The Effects of Mixhers HERTIME Supplements on Menstrual Symptoms August 30, 2023 December 20, 2023
NCT01385709 Completed The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels August 2008 August 2013
NCT01875718 Completed Phase 1/Phase 2 A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD) January 2013 June 2014
NCT00516113 Completed Phase 4 A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria October 2000 November 2002
NCT06227676 Completed Phase 2/Phase 3 Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25 July 21, 2022 October 31, 2022
NCT02508103 Completed Phase 2/Phase 3 Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study July 2015 July 2016
NCT03449979 Completed N/A Single Session of tACS in a Depressive Episode September 19, 2018 August 16, 2019
NCT06462391 Not yet recruiting N/A Adapting and Piloting Acceptance and Commitment Therapy (ACT) for Severe Premenstrual Mood Symptoms July 1, 2024 December 31, 2026
NCT05813366 Not yet recruiting N/A Combined Effect of Tryptophan Rich Diet and Acupuncture on Depression Related to Premenstrual Dysphoric Disorder April 25, 2023 July 25, 2023
NCT05098574 Recruiting Phase 2 Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder November 30, 2022 June 30, 2024
NCT00089414 Terminated Phase 2 Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives July 2004 June 2010
NCT02362191 Terminated N/A Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD March 2015 March 2020
NCT02448836 Unknown status N/A Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD) June 2015
NCT01217775 Unknown status Phase 3 Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder March 2016 July 2017
NCT04123483 Withdrawn Phase 4 EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders November 2019 November 2022
MeSH unique ID (MeSH (Medical Subject Headings))
D065446